SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-003313
Filing Date
2019-02-27
Accepted
2019-02-27 13:24:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 32042
2 filename2.txt TEXT-EXTRACT 1222
  Complete submission text file 0000000000-19-003313.txt   46063
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filed for) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)